Please try another search
For the six months ended 31 December 2021, Oventus Medical Ltd revenues increased 1% to A$554K. Net loss increased 10% to A$5.1M. Revenues reflect Australia segment increase of 34% to A$179K, Australia segment increase of 34% to A$179K. Higher net loss reflects North America segment loss increase of 31% to A$2.7M, Australia segment loss increase of 7% to A$2.4M, North America segment loss increase of 31% to A$2.7M.
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Revenue | 0.55 | 0.54 | 0.55 | 0.23 |
Gross Profit | 0.29 | 0.15 | 0.25 | 0.1 |
Operating Income | -5.07 | -5.49 | -4.47 | -5.07 |
Net Income | -5.14 | -5.15 | -4.68 | -5 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Assets | 9.86 | 15.08 | 11.01 | 14.33 |
Total Liabilities | 1.87 | 2.46 | 2.79 | 2.11 |
Total Equity | 7.99 | 12.62 | 8.22 | 12.22 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -4.48 | -6.92 | -2.72 | -7.67 |
Cash From Investing Activities | -0.09 | -1.53 | -0.88 | -1.51 |
Cash From Financing Activities | -0.3 | 9.18 | -0.03 | 14.76 |
Net Change in Cash | -4.81 | 0.7 | -3.62 | 5.46 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review